GenoMom is a patented, non-invasive prenatal test (NIPT) used to detect specific chromosomal abnormalities in a developing fetus using cell-free fetal DNA present in maternal blood. GenoMom was developed by geneticists from Korea and launched in 2016 after a clinical trial of 4,956 cases. The results of the trial are one of the best in the region with a zero (0) false negative result and specifically developed (and clinically tested) for Asian DNA.
We highly recommend GenoMom for pregnant mothers, ages 35 years and above. This is because women of advanced maternal age are at an increased risk of producing a fetus with chromosomal abnormalities.
GenoMom can be used as early as 10 weeks gestation to test singleton and twins (identical, fraternal, and vanishing twins) for the following trisomies:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edward syndrome)
- Trisomy 13 (Patau Syndrome)
Eligibility: 12 weeks gestation
Samples: 2 x 10ml tubes of blood from Mother
Testing timeline: 5-7 working days from receipt of samples at laboratory.
Results: Softcopy (results will be emailed).
- Vanishing twins
- Fetal gender information (99.9% sensitivity)
- Sex chromosome aneuploidy (XO, XXY, XXX, XYY) (95% sensitivity)
- Autosomal aneuploidies (Trisomy 9, 16, 22)
- 8 micro-deletion syndromes (1P36, Cri-du-Chat, 2q33.1, Jacobsen, Prader-Willi /Angelman, DiGeorgeII, 16p12.2, Van der Woude)